Edarbyclor Oral Tablet 40-12.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Edarbyclor: Oral tablet (40-12.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_18533.JPG
Edarbyclor 40mg-12.5mg Tablet
Takeda Pharmaceuticals North America Inc
Pill Identification: A/C 40/12.5 
Drug Image file DrugItem_18533.JPG
Edarbyclor 40mg-12.5mg Tablet
Takeda Pharmaceuticals North America Inc
Pill Identification: A/C 40/12.5 

What is this Medicine?

AZILSARTAN; CHLORTHALIDONE (ay zil SAR tan; klor THAL i done) is a combination of an angiotensin II receptor blocker (ARB) and a diuretic. It is used to treat high blood pressure.

CVS Pharmacy Patient Statistics for Edarbyclor: Oral tablet(40-12.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Edarbyclor 40mg-12.5mg Tablet

NDC: 647640944
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertension

Storage Information
Protect from light
Store in original container
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Edarbyclor 40mg-12.5mg Tablet
Drug Image file DrugItem_18533.JPG
Takeda Pharmaceuticals North America Inc
Pill Identification: A/C 40/12.5 
Shape: round
Color: red
Drug Image file DrugItem_18532.JPG
Takeda Pharmaceuticals North America Inc
Pill Identification: A/C 40/12.5 
Shape: round
Color: red

Reported Side Effects for Edarbyclor 40mg-12.5mg Tablet

Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
1.7%*
Severity: MODERATE
Onset: RAPID
Low Potassium Levels Incidence:
1.7%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
8.9%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Edarbyclor 40mg-12.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Edarbyclor 40mg-12.5mg Tablet(Chlorthalidone)
Alcohol and Antihypertensives(Chlorthalidone)
Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Edarbyclor

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.